{"id":292740,"date":"2024-11-29T16:45:52","date_gmt":"2024-11-29T16:45:52","guid":{"rendered":"https:\/\/www.artefact.com\/?post_type=blog&#038;p=292740"},"modified":"2024-12-18T11:00:52","modified_gmt":"2024-12-18T11:00:52","slug":"pfizer-at-the-ai-for-health-summit-ai-on-a-mission-to-make-drug-development-faster-and-smarter","status":"publish","type":"blog","link":"https:\/\/www.artefact.com\/es\/blog\/pfizer-at-the-ai-for-health-summit-ai-on-a-mission-to-make-drug-development-faster-and-smarter\/","title":{"rendered":"PFIZER en la Cumbre de IA para la Salud - IA: En una misi\u00f3n para hacer el desarrollo de f\u00e1rmacos m\u00e1s r\u00e1pido e inteligente"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_color: var(--awb-color6);--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-background-color:var(--awb-color1);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1 description\" style=\"--awb-text-color:var(--awb-color5);--awb-text-font-family:&quot;PT Serif&quot;;--awb-text-font-style:normal;--awb-text-font-weight:400;\"><p>Cumbre de la IA para la Salud - Edici\u00f3n 2024<\/p>\n<p>Principales conclusiones del debate sobre \u201cInteligencia Artificial: On a mission to make drug development faster and smarter\u201d entre Reda Guiha, Country President France en Pzifer, y Damien Gromier CEO &amp; Founder of AI for Health.<\/p>\n<\/div><\/div><\/div><\/div><\/div><article class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_color: var(--awb-color6);--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-background-color:var(--awb-color1);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"max-width:calc( 1440px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-video fusion-youtube\" style=\"--awb-max-width:670px;--awb-max-height:377px;--awb-align-self:center;--awb-width:100%;\"><div class=\"video-shortcode\"><div class=\"fluid-width-video-wrapper\" style=\"padding-top:56.27%;\" ><iframe title=\"Reproductor de video de YouTube 1\" src=\"https:\/\/www.youtube.com\/embed\/6p2wX7HakSk?wmode=transparent&autoplay=0\" width=\"670\" height=\"377\" allowfullscreen allow=\"autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture;\"><\/iframe><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:10%;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-image-element\" style=\"text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\"fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/marketing.artefact.com\/l\/597421\/2024-12-11\/j39z22\" target=\"_self\" aria-label=\"S\u00edntesisAIFH-GIF\" rel=\"noopener\"><img decoding=\"async\" width=\"700\" height=\"404\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27700%27%20height%3D%27404%27%20viewBox%3D%270%200%20700%20404%27%3E%3Crect%20width%3D%27700%27%20height%3D%27404%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/www.artefact.com\/\/wp-content\/uploads\/2024\/11\/SyntheseAIFH-GIF.gif\" alt class=\"lazyload img-responsive wp-image-294955\"\/><\/a><\/span><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_2 1_2 fusion-flex-column fusion-flex-align-self-center\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div style=\"text-align:center;\"><a class=\"fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span fusion-button-default-type\" target=\"_self\" href=\"https:\/\/marketing.artefact.com\/l\/597421\/2024-12-11\/j39z22\" rel=\"noopener\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Descargar el informe<\/span><\/a><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-2\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>Pfizer, mundialmente conocida por su vacuna COVID-19, est\u00e1 aprovechando la artificial intelligence para revolucionar el desarrollo de f\u00e1rmacos. La IA se considera un factor de cambio, que repercute en todas las fases del proceso farmac\u00e9utico, desde la investigaci\u00f3n precl\u00ednica hasta el acceso de los pacientes y la fabricaci\u00f3n, con aplicaciones tanto operativas como transformadoras.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Impacto operativo de la IA<\/h2><\/div><div class=\"fusion-text fusion-text-3\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>La IA mejora las tareas farmac\u00e9uticas cotidianas, como la preparaci\u00f3n de los expedientes reglamentarios, los informes de seguridad y la eficacia de la fabricaci\u00f3n. Al optimizar estos procesos, la IA no s\u00f3lo ahorra tiempo, sino que tambi\u00e9n reduce la huella de carbono y los ciclos de desarrollo, mejorando el rendimiento operativo general.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Aplicaciones transformadoras en el desarrollo de f\u00e1rmacos<\/h2><\/div><div class=\"fusion-text fusion-text-4\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>La IA permite avances significativos en el descubrimiento precl\u00ednico de f\u00e1rmacos y en el desarrollo cl\u00ednico. Por ejemplo, durante la vacuna COVID-19, la IA redujo los tiempos de desarrollo precl\u00ednico de cuatro a\u00f1os a cuatro meses al reducir las pruebas de mol\u00e9culas de 3 millones de compuestos a 600. Del mismo modo, AI aceler\u00f3 los plazos de los ensayos cl\u00ednicos de la vacuna COVID-19, lanzando ensayos en seis pa\u00edses e inscribiendo a 46.000 participantes en s\u00f3lo cuatro meses, un proceso que tradicionalmente lleva a\u00f1os.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Reducci\u00f3n de costes y riesgos en el desarrollo cl\u00ednico<\/h2><\/div><div class=\"fusion-text fusion-text-5\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>La IA aborda los crecientes costes de desarrollo de f\u00e1rmacos, que actualmente se acercan a los $4.000 millones por producto. Herramientas como la IA generativa agilizan el dise\u00f1o de protocolos de ensayos cl\u00ednicos, la preparaci\u00f3n de expedientes reglamentarios y la limpieza data, reduciendo costes y plazos. La IA traslacional garantiza el cumplimiento de las normativas locales y mejora los procesos de consentimiento de los pacientes, lo que demuestra el papel de la IA en la agilizaci\u00f3n y la eficacia de los ensayos.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">La importancia de la data en el \u00e9xito de la IA<\/h2><\/div><div class=\"fusion-text fusion-text-6\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>Data sirve de base a la innovaci\u00f3n en IA. Con d\u00e9cadas de data cl\u00ednico y millones de puntos de data, Pfizer aprovecha la IA para mejorar las tasas de \u00e9xito cl\u00ednico, duplic\u00e1ndolas hasta casi 20% en comparaci\u00f3n con la media del sector de 7-10%. Sin embargo, lograr estos resultados requiere conjuntos de data robustos, de alta calidad y diversos.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Las colaboraciones como estrategia clave<\/h2><\/div><div class=\"fusion-text fusion-text-7\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>Las asociaciones son esenciales para hacer avanzar la IA en la atenci\u00f3n sanitaria. Pfizer colabora en todos los sectores, con centros acad\u00e9micos y startups, como se ve en su implicaci\u00f3n con IMI Big Picture, que construye una vasta database de 3 millones de muestras de enfermedades. En Francia, el Pfizer Healthcare Hub conecta a 40 startups con la experiencia global, fomentando la innovaci\u00f3n y acelerando el desarrollo de soluciones centradas en el paciente.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">La IA y la oportunidad de liderazgo de Europa<\/h2><\/div><div class=\"fusion-text fusion-text-8\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>La IA y las plataformas bioterap\u00e9uticas representan revoluciones convergentes en las ciencias de la vida, creando un renacimiento de la innovaci\u00f3n. Mientras que Europa va a la zaga de EE.UU. en aprobaci\u00f3n de medicamentos e innovaci\u00f3n, Francia tiene potencial para liderar la IA. Conseguirlo requiere un marco regulador unificado, inversiones escalables y una colaboraci\u00f3n transfronteriza para superar las barreras culturales y ling\u00fc\u00edsticas.<\/p>\n<\/div><div class=\"fusion-title title fusion-title-7 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:var(--awb-color6);--awb-margin-bottom-small:8px;--awb-font-size:30px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;PT Serif&quot;;font-style:normal;font-weight:700;margin:0;letter-spacing:1.6px;font-size:1em;--fontSize:30;line-height:1.47;\">Conclusi\u00f3n<\/h2><\/div><div class=\"fusion-text fusion-text-9\" style=\"--awb-font-size:20px;--awb-line-height:1.6;--awb-letter-spacing:var(--awb-typography4-letter-spacing);--awb-text-transform:var(--awb-typography4-text-transform);--awb-text-color:var(--awb-color5);--awb-text-font-family:var(--awb-typography4-font-family);--awb-text-font-weight:var(--awb-typography4-font-weight);--awb-text-font-style:var(--awb-typography4-font-style);\"><p>La IA est\u00e1 transformando el desarrollo de f\u00e1rmacos y presenta una oportunidad para que Europa, y en particular Francia, lidere la innovaci\u00f3n en ciencias de la vida. Al centrarse en las asociaciones, la calidad data y la escalabilidad, Pfizer prev\u00e9 un futuro en el que la IA impulse soluciones sanitarias m\u00e1s r\u00e1pidas, inteligentes y accesibles.<\/p>\n<\/div><\/div><\/div><\/div><\/article><\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer est\u00e1 aprovechando la IA para revolucionar el desarrollo de f\u00e1rmacos. La IA se considera un cambio de juego, que repercute en todas las fases del proceso farmac\u00e9utico, desde la investigaci\u00f3n precl\u00ednica hasta el acceso de los pacientes y la fabricaci\u00f3n, con aplicaciones tanto operativas como transformadoras.<\/p>","protected":false},"featured_media":292741,"parent":0,"template":"","meta":{"_acf_changed":false,"ep_exclude_from_search":false},"blog-category":[21931],"blog-language":[2991],"class_list":["post-292740","blog","type-blog","status-publish","has-post-thumbnail","hentry","blog-category-healthcare","blog-language-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/blog\/292740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/types\/blog"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/media\/292741"}],"wp:attachment":[{"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/media?parent=292740"}],"wp:term":[{"taxonomy":"blog-category","embeddable":true,"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/blog-category?post=292740"},{"taxonomy":"blog-language","embeddable":true,"href":"https:\/\/www.artefact.com\/es\/wp-json\/wp\/v2\/blog-language?post=292740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}